ETANERCEPT

Etanercept is a TNF‑α inhibitor reducing inflammation in autoimmune diseases. Side effects include infections, injection-site reactions, and headache.

SKU: e2b96143f882 Category: Tag:

Product Description


Mechanism of Action

Etanercept is a fusion protein composed of the TNF receptor p75 linked to the Fc portion of IgG1. It binds soluble TNF‑α and TNF‑β, preventing their interaction with cell‑surface receptors and inhibiting downstream NF‑κB–mediated inflammatory signalling. This reduces cytokine‑driven inflammation in autoimmune‑disease models.

Benefits and Advantages

Used in TNF‑pathway research, autoimmune‑inflammation modelling, cytokine‑neutralization assays, and biologic‑mechanism pharmacology.

Side Effects and Risks

Risks include serious infections, injection‑site reactions, malignancy risk signals, demyelinating disorders and cytopenias. Handle with biologic‑TNF‑inhibitor precautions.

Datasheet


Molecular Formula

Protein

Molecular Weight

150000.0 g/mol

CAS Number

185243-69-0

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

Ammonium metavanadate; 7803-55-6; Ammonium monovanadate; Ammonium vanadate(V); Ammonium metavanadate (NH4VO3)

IUPAC/Chemical Name

TNF receptorFc fusion protein

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download